source
- Cigna to End Coverage of GLP-1 Weight-Loss Drugs Wegovy and Zepbound for Employees Starting July 1Cigna announced it will stop covering GLP-1 weight-loss medications for its employee health plan, effective July 1. The decision affects drugs such as Novo Nordisk’s Wegovy and Eli Lilly’s Zepboun…
- NIH terminates $82 million outbreak research network, weakening pandemic preparednessIn 2020 the National Institutes of Health created a network of ten centers to expand knowledge on re‑emerging and emerging infectious diseases. The program was funded with $82 million over five yea…